PharmaBoardroom

Scaling Healthcare’s Digital Transformation with AI

Digital marketing expert Buck Dossey expounds the importance of soliciting user data to improve patient experiences and the ways in which AI can be…

5 Top European Mid-Cap CEOs To Know

Bringing together insights from the heads of some of Europe's most prominent mid-cap pharma firms. The leaders of Ipsen, Genmab, Pierre Fabre, Esteve…

Marc Comas – Managing Director, Accord Healthcare Iberia

Marc Comas, managing director of Accord Healthcare Iberia, highlights the footprint of the company as the leading generics and biosimilars player in…

Philippe Archinard – CEO, Transgene, France

Phillipe Archinard CEO of Transgene shares insights on the latest technologies being developed by the gene therapy specialist, explains how France’s…

AI in Clinical Trials: Improving Efficiency, Reducing Costs

Paul Bleicher, CEO at OptumLabs, and one of the speakers at the FT US Pharma & Biotech Summit on May 14, shares insights on the benefits we will…

William (Wei) Cao – Founder, Chairman & CEO, Gracell,…

William Wei Cao, chairman and CEO of Gracell, shares the fascinating journey that inspired him to establish Gracell in Shanghai to tackle the four big…

USA: The Biosimilars Trade Opportunity

Chip Davis of the Association for Accessible Medicines argues for greater provision for access to affordable medicines – including biosimilars –…

André Choulika – Chairman & CEO, Cellectis, France

André Choulika, Chairman and CEO of Cellectis, discusses how UCART will revolutionize cell therapy as a universal gene-edited solution as opposed to…

Vincent Pont – President, Laboratoire Arrow, France

Vincent Pont, president of Laboratoire Arrow, explains the company’s history, its collaboration with Aurobindo, the Indian generic pharmaceuticals…

Bertrand de Lavenne – General Manager, Mylan France

Bertrand de Lavenne, general manager of Mylan France, explains how the affiliate is positioned within the group’s operations and how the Mylan…

John Yu – CEO, CGeneTech, China

Dr John Yu, co-founder and CEO of CGeneTech, shares the exciting story behind the company’s establishment in 2010; its balanced philosophy on new…

Pascal Brière – President, Biogaran, France

Pascal Brière, president of Biogaran, the leading French domestic player in generics, reflects on the development of the generic market since the…

Tagged with GEN